Postural deformities in patients with Parkinson disease (clinical and social aspects)
https://doi.org/10.31363/2313-7053-2019-4-2-112-117
Abstract
The analysis was presentedabout the dynamics of the functional and psychological state and quality of life of patients with trunk deformities in Parkinson’s diseaseusing Dysport. The optimal regimens was reflected about the administration of botulinum toxin for patients with camptocormia and Pisa syndrome.
About the Authors
I. V. Fursova
Bekhterev National Medical Research Center for Psychiatry and Neurology
Russian Federation
Saint-Petersburg.
Russian Federation
Saint-Petersburg.
V. A. Mikhailov
Bekhterev National Medical Research Center for Psychiatry and Neurology
Russian Federation
Saint-Petersburg.
Russian Federation
Saint-Petersburg.
D. V. Zakharov
Bekhterev National Medical Research Center for Psychiatry and Neurology
Russian Federation
Saint-Petersburg.
Russian Federation
Saint-Petersburg.
A. P. Kovalenko
Military Medical Academy S.M. Kirova of the Ministry of Defense of the Russian Federation
Russian Federation
Saint-Petersburg.
Russian Federation
Saint-Petersburg.
References
1. Г. Райхель, Терапевтическое руководство спастичность-дистонии. 2013; 153-157.
2. Коваленко А.П. Использование ботулинотерапии для лечения камптокормии у больных с болезнью Паркинсона (клинический случай) // Болезнь Паркинсона и расстройства движения. Руководство для врачей. По мат. III Национального конгресса по болезни Паркинсона и расстройствам движения (с международным участием) / Под ред. проф. С.Н. Иллариошкина и проф. О.С. Левина. Москва. 2014; 198-200.
3. Ashour R., Jankovic J. Joint and skeletal deformities in Parkinson's desease, multiple system atrophy and progressive supranuclear palsy. Mov. Disoderers 2006; 21: 1856-1863.
4. Ashour R., Tintner R., Jankovic J., Striatal defor-mities of the hand and foot in Parkinson’s disease, http://neurology.thelancet.com.2005;4:423-43.
5. Azher SN, Jankovic J. Camptocormia: pathogenesis, classification and response to therapy. Neurology. 2005; 65:355-359.
6. Bhattacharya KF, Giannakikou I, Munroe N, Chaudhuri KR. Primary anticholinergic-responsive Pisa syndrome. MovDisord 2000; 15: 1285-87
7. BlochF, HouetoJL, TezenaduMontcelS, etal. Parkin-son’s disease with camptocormia. J Neurol Neurosurg Psychiatry. 2006; 77:1223-1228;
8. Bonanni L., Thomas A., Varanese S., Scorrano V., and Onofrj M.; Botulinum Toxin Treatment of Lateral Axial Dystonia in Parkinsonism. Movement Disorders. 2007; 206:2097-2103.
9. Jankovic J, Tintner R. Dystonia and Parkinsonism. Parkinson Dis Relat Disord. 2001; 8:109-112.
10. Karen M Doherty, Bart P van de Warrenburg, Maria Cecilia Peralta, Laura Silveira-Moriyama, Jean-Philippe Azulay, Oscar S Gershanik, Bastiaan R Bloem. Postural deformities in Parkinson’s disease. www.thelancet.com/neurology Published online. 2011. DOI:10.1016/S1474-4422(11)70067-9
11. Lepoutre AC, Devos D, Blanchard-Dauphin A. A specific clinical pattern of camptocormia in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2006; 77:1229-1234.
12. Reichel G, Kirchhofer U, Stenner A. Camptocormia-segmental dystonia. Proposal of a new definition for an old disease. Nervenarzt. 2001; 72:281-285.
13. Salvatori FM,Injection of the iliopsoas muscle with botulinum toxin in camptocormia. Mov.Disord. 2009; 24:316.
14. Strickland & Bertoni. 2004.
15. Tassorelli C, MD, PhD, Furnari A., MD, Buscone S., MD, Alfonsi E, MD, Pacchetti C., MD, Zangaglia R, MD, Pichiecchio A., MD, Bastianello S., MD,Lozza A., MD, Allena M., MD, Bolla M., MD, Sandrini G., MD, Nappi G., MD and Martignoni E., MD. Pisa. Syndrome in Parkinson’s Disease: Clinical, Electromyographic and Radiological Characterization. Movement Disorders. 2012; 27: 227-235.
Review
For citations:
Fursova I.V., Mikhailov V.A., Zakharov D.V., Kovalenko A.P. Postural deformities in patients with Parkinson disease (clinical and social aspects). V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2019;(4-2):112-117. (In Russ.) https://doi.org/10.31363/2313-7053-2019-4-2-112-117
Views:
1020
Email this article 